Societal CDMO Inc
NASDAQ:SCTL
Societal CDMO Inc
Total Current Liabilities
Societal CDMO Inc
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Societal CDMO Inc
NASDAQ:SCTL
|
Total Current Liabilities
$50m
|
CAGR 3-Years
86%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Liabilities
$48.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Liabilities
$25.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Liabilities
$40.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Liabilities
$25.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Liabilities
$18.6B
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
See Also
What is Societal CDMO Inc's Total Current Liabilities?
Total Current Liabilities
50m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Total Current Liabilities amounts to 50m USD.
What is Societal CDMO Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
15%
Over the last year, the Total Current Liabilities growth was 119%. The average annual Total Current Liabilities growth rates for Societal CDMO Inc have been 86% over the past three years , 12% over the past five years , and 15% over the past ten years .